UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047278
Receipt number R000053916
Scientific Title Features of Gut Prokaryotic Virome in Japanese Patients with Inflammatory bowel disease
Date of disclosure of the study information 2022/03/24
Last modified on 2025/04/10 18:16:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Features of Gut Virome in Japanese Patients with Inflammatory bowel disease

Acronym

Gut Virome

Scientific Title

Features of Gut Prokaryotic Virome in Japanese Patients with Inflammatory bowel disease

Scientific Title:Acronym

Gut Prokaryotic Virome

Region

Japan


Condition

Condition

Inflammatory bowel disease

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine the composition of intestinal phage and bacterial flora in patients with inflammatory bowel disease.

Basic objectives2

Others

Basic objectives -Others

To examine whether there are abnormalities in the composition of intestinal phage in IBD.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Analysis of the intestinal virome

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Ulcerative colitis
Crohn's disease
healthy control

over 20 years old

Persons who can obtain the information in writing from the individual.

Key exclusion criteria

Persons with colorectal cancer
Those who are taking anticoagulants.

Persons who are unable to give their consent


Persons who are judged to be unsuitable as examinees by the principal investigator .

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Masashi
Middle name
Last name Ohno

Organization

Shiga University of Medical Science

Division name

Gastroenterology and Hematology

Zip code

520-2192

Address

Seta-Tsukinowa Otsu

TEL

0775482217

Email

hqmed2@belle.shiga-med.ac.jp


Public contact

Name of contact person

1st name Takayuki
Middle name
Last name Imai

Organization

Shiga University of Medical Science

Division name

Gastroenterology and Hematology

Zip code

520-2192

Address

Seta-Tsukinowa Otsu

TEL

0775482217

Homepage URL


Email

timai@belle.shiga-med.ac.jp


Sponsor or person

Institute

Shiga University of Medical Science

Institute

Department

Personal name



Funding Source

Organization

self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shiga University of Medical Science

Address

Seta-Tsukinowa Otsu

Tel

0775483576

Email

hqrec@belle.shiga-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 03 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 08 Month 30 Day

Date of IRB

2019 Year 09 Month 02 Day

Anticipated trial start date

2019 Year 09 Month 03 Day

Last follow-up date

2024 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2022 Year 03 Month 24 Day

Last modified on

2025 Year 04 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053916